Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro. [electronic resource] by
- Salpini, R
- Surdo, M
- Cortese, M F
- Palumbo, G A
- Carioti, L
- Cappiello, G
- Spanò, A
- Trimoulet, P
- Fleury, H
- Vecchiet, J
- Pasquazzi, C
- Mirabelli, C
- Scutari, R
- Sacco, A
- Alkhatib, M
- Missale, G
- Francioso, S
- Sarmati, L
- Andreoni, M
- Angelico, M
- Ceccherini-Silberstein, F
- Levrero, M
- Perno, C F
- Belloni, L
- Svicher, V
Producer: 20191104
In:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 25
Availability: No items available.
|